IV Anesthetics

Intravenous (IV) anesthetics, such as propofol, etomidate, ketamine, benzodiazepines, and barbiturates, play a pivotal role in the induction of anesthesia. A majority of these IV anesthetics, including propofol, etomidate, benzodiazepines, and barbiturates, exert their action by enhancing the chloride current through the GABAA receptor complex, leading to a general decrease in CNS function. Propofol, notably lipophilic, ensures a swift onset due to its rapid distribution into high-perfusion lipophilic tissues like the brain, yet has a brief duration of action because of its quick redistribution to tissues such as skeletal muscle and fat. Despite its advantages for induction and prolonged sedation, clinicians should be wary of its lipid solution, which can trigger anaphylaxis, its association with high serum triglycerides, and its pronounced vasodilation causing hypotension. Propofol lacks analgesic effects and can significantly depress respiratory function.

Etomidate, another agent for anesthesia induction, doesn't offer analgesic properties but stands out due to its preservation of cardiovascular stability and its unique side effect of adrenocortical suppression. On the other hand, ketamine acts by inhibiting the NMDA receptor complex and is renowned for causing dissociative anesthesia, retaining both respiratory function and consciousness. Ketamine serves as a powerful analgesic suitable for conscious sedation but can lead to emergence reactions, like vivid dreams and hallucinations. Additionally, its cardiovascular stimulation arises from catecholamine release, which further induces bronchodilation. Benzodiazepines offer anxiolytic and sedative-hypnotic properties, making them apt for conscious sedation during minor operations like colonoscopies. Lastly, IV barbiturates, such as thiopental, have lost favor in modern practice but were once favored for their fast-acting, highly lipid-soluble properties in anesthesia inductio
---

The realm of IV anesthetics is intricate, with no single drug able to accomplish all the desirable effects of anesthesia: unconsciousness, amnesia, analgesia, inhibition of autonomic reflexes, and skeletal muscle relaxation. The use of these drugs often involves combinations to cater to different stages of general anesthesia: induction, maintenance, and recovery. Central to the understanding of their action is the GABA-A receptor, with most IV anesthetics potentiating its neuro-inhibitory effects.

Propofol, a standout among IV anesthetics, is frequently employed in anesthesia induction due to its swift onset and brief duration of action. However, it's associated with challenges such as significant hypotension, respiratory depression, elevated serum triglycerides, and potential anaphylactic reactions from its egg and soy constituents. The profile of etomidate shines for its ability to maintain cardiovascular stability, making it a valuable choice for patients with fragile hemodynamics, even as it may induce adrenocortical suppression. Ketamine diverges by targeting the NMDA receptor, ushering in 'dissociative anesthesia' that maintains both consciousness and respiratory function, while augmenting cardiovascular activity. Briefly, benzodiazepines serve their role as perioperative anxiolytics and sedative-hypnotics, while barbiturates, historically pivotal in anesthesia induction, are now infrequently utilized